5
Deep Health AI
DEEPDIAMONDINDIALTD NSE
Deep Health AI
Consumer GoodsNSE: DEEPDIAMONDINDIALTD BSE: 539559 Jewellery & Watches
Key Fundamentals
MicrocapJewellery & WatchesConsumer GoodsMarket Cap
₹26.49 Cr
Volatility
Moderate
P/E Ratio
-26
EBITDA
₹-2.61 Cr
Return on Equity
3.92%
Debt to Equity
0.01
Book Value
₹3.56
EPS
₹0.12
52W High
₹10.29
52W Low
₹1.65
Tapetide Score
Data-driven rating, 0–100. How it works →
Key Insights
Strengths
4- Company has reduced debt.
- Company is almost debt free.
- Stock is trading at 0.51 times its book value
- Stock is providing a good dividend yield of 5.52%.
Weaknesses
4- Promoter holding is low: 0.03%
- Company has a low return on equity of 10.4% over last 3 years.
- Company has high debtors of 251 days.
- Working capital days have increased from 140 days to 405 days
Growth Rate
Revenue Growth
113% higher than
3Y
Net Income Growth
26.67% lower than
3Y
Cash Flow Change
104% higher than
3Y
ROE
92.16% higher than
3Y
ROCE
35.59% level than
3Y
EBITDA Margin (Avg.)
-151% higher than
3Y
Quarterly Results
| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.3 | 0.89 | 0.86 | 1.7 | 0.51 | 0.3 | 0 | 0.45 | 0.15 | 3.35 | 0.5 | 0.25 | 0.45 |
| Expenses | 0.22 | 1.47 | 0.77 | 2.03 | 0.29 | 0.17 | 0.15 | 0.21 | 0.2 | 0.12 | 0.39 | 0.19 | 2.51 |
| Operating Profit | 0.08 | -0.58 | 0.09 | -0.33 | 0.22 | 0.13 | -0.15 | 0.24 | -0.05 | 3.23 | 0.11 | 0.06 | -2.06 |
| OPM % | 26.67% | -65.17% | 10.47% | -19.41% | 43.14% | 43.33% | — | 53.33% | -33.33% | 96.42% | 22% | 24% | -457.78% |
| Other Income | 0.27 | 0.26 | 0.55 | 0.54 | 0.19 | 0.09 | 0.22 | 0.25 | 0.19 | 0.16 | 3.71 | -5.6 | 0.17 |
| Interest | 0.12 | 0.03 | 0.05 | 0.21 | 0.03 | 0.02 | 0.01 | 0.03 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Depreciation | 0 | 0 | 0.01 | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| PBT | 0.23 | -0.35 | 0.58 | -0.01 | 0.38 | 0.2 | 0.06 | 0.46 | 0.13 | 3.38 | 3.81 | -5.55 | -1.9 |
| Tax % | 26.09% | 0% | 10.34% | 1000% | 26.32% | 25% | 83.33% | 8.7% | 23.08% | 25.15% | 16.01% | -18.56% | 0% |
| Net Profit | 0.17 | -0.35 | 0.52 | -0.11 | 0.29 | 0.15 | 0.01 | 0.41 | 0.09 | 2.53 | 3.2 | -4.52 | -1.9 |
| EPS in Rs | 0.02 | -0.04 | 0.05 | -0.01 | 0.03 | 0.02 | 0 | 0.04 | 0.01 | 0.18 | 0.22 | -0.31 | -0.13 |
Profit & Loss
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 3.13 | 1.17 | 3.29 | 1.66 | 1.25 | 0.81 | 0.51 | 1.39 | 7.67 | 2.56 | 1.25 | 4.25 | 4.55 |
| Expenses | 3.04 | 1.4 | 3.38 | 1.94 | 1.54 | 1.11 | 0.74 | 1.38 | 6.03 | 2.8 | 0.8 | 0.91 | 3.21 |
| Operating Profit | 0.09 | -0.23 | -0.09 | -0.28 | -0.29 | -0.3 | -0.23 | 0.01 | 1.64 | -0.24 | 0.45 | 3.34 | 1.34 |
| OPM % | 2.88% | -19.66% | -2.74% | -16.87% | -23.2% | -37.04% | -45.1% | 0.72% | 21.38% | -9.38% | 36% | 78.59% | 29.45% |
| Other Income | 0.16 | 0.19 | 0.22 | 0.28 | 0.28 | 0.29 | 0.26 | 0.26 | 0.23 | 1.09 | 0.75 | -1.54 | -1.56 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.13 | 0.26 | 0.09 | 0.03 | 0.04 |
| Depreciation | 0.03 | 0.05 | 0.04 | 0.02 | 0.02 | 0.02 | 0.02 | 0 | 0.01 | 0.01 | 0.01 | 0.01 | 0 |
| PBT | 0.22 | -0.09 | 0.09 | -0.02 | -0.03 | -0.03 | 0.01 | 0.27 | 1.73 | 0.58 | 1.1 | 1.76 | -0.26 |
| Tax % | 31.82% | -11.11% | 22.22% | 0% | 0% | 0% | 500% | 25.93% | 27.75% | 27.59% | 21.82% | 26.14% | — |
| Net Profit | 0.15 | -0.07 | 0.07 | -0.02 | -0.02 | -0.03 | -0.05 | 0.2 | 1.26 | 0.42 | 0.86 | 1.3 | -0.69 |
| EPS in Rs | 0.02 | -0.01 | 0.01 | 0 | 0 | 0 | -0.01 | 0.02 | 0.13 | 0.04 | 0.09 | 0.09 | -0.04 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 110.92% | — |
Balance Sheet
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 3.2 | 3.2 | 3.2 | 3.2 | 3.2 | 3.2 | 3.2 | 3.2 | 4.81 | 4.81 | 4.81 | 14.42 |
| Reserves | 4.43 | 4.36 | 4.44 | 4.45 | 4.38 | 4.3 | 4.28 | 4.48 | 9.92 | 15.62 | 17.54 | 37.12 |
| Borrowings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.86 | 1.66 | 0.61 | 0.37 |
| Other Liabilities | 0.15 | 0.22 | 0.24 | 0.07 | 0.07 | 0.3 | 0.11 | 0.06 | 1.29 | 0.98 | 0.99 | 0.34 |
| Total Liabilities | 7.78 | 7.78 | 7.88 | 7.72 | 7.65 | 7.8 | 7.59 | 7.74 | 19.88 | 23.07 | 23.95 | 52.25 |
| Fixed Assets | 0.4 | 0.36 | 0.32 | 0.3 | 0.29 | 0.27 | 0 | 0 | 4.47 | 4.46 | 4.45 | 0.01 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0.13 | 0.1 | 0.16 | 0.17 | 0.25 | 0.19 | 0.26 | 0.2 | 0 | 3.56 | 5.59 | 32.99 |
| Other Assets | 7.25 | 7.32 | 7.4 | 7.25 | 7.11 | 7.34 | 7.33 | 7.54 | 15.41 | 15.05 | 13.91 | 19.25 |
| Total Assets | 7.78 | 7.78 | 7.88 | 7.72 | 7.65 | 7.8 | 7.59 | 7.74 | 19.88 | 23.07 | 23.95 | 52.25 |
Cash Flow
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | -0.39 | -0.19 | 0.08 | -0.69 | -0.25 | -0.28 | -0.15 | 0.55 | 3.23 | -5.41 | 0.19 | -3.64 |
| Investing | 0.06 | 0.23 | 0.18 | 0.29 | 0.13 | 0.3 | 0.27 | 0.29 | -4.03 | -2.25 | -0.23 | -29.2 |
| Financing | 0.5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5.79 | 5.01 | 0 | 37.87 |
| Net Cash Flow | 0.17 | 0.04 | 0.26 | -0.4 | -0.12 | 0.02 | 0.12 | 0.84 | 4.99 | -2.65 | -0.04 | 5.03 |
| Free Cash Flow | -0.39 | -0.19 | 0.08 | -0.69 | -0.26 | -0.28 | -0.08 | 0.55 | -1.25 | -5.41 | 0.19 | -3.64 |
| CFO/OP | -433 | 65 | -156 | 246 | 86 | 93 | 65 | 5,700 | 203 | 2,254 | 42 | -61 |
Ratios
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 213 | 455 | 142 | 167 | 169 | 203 | 293 | 118 | 128 | 208 | 149 | 251 |
| Inventory Days | 447 | 1,622 | 401 | 878 | 1,120 | 1,943 | 3,433 | 1,208 | 86.55 | 265 | 1,241 | — |
| Days Payable | 0 | 69.3 | 19.28 | 0 | 0 | 0 | 0 | 11.65 | 84.11 | 237 | 1,630 | — |
| Cash Conversion Cycle | 660 | 2,008 | 524 | 1,045 | 1,290 | 2,146 | 3,726 | 1,314 | 130 | 236 | -240 | 251 |
| Working Capital Days | 799 | 2,131 | 736 | 886 | 1,139 | 1,663 | 2,784 | 948 | -60.91 | -27.09 | 40.88 | 405 |
| ROCE % | 3.01% | -1.18% | 1.18% | -0.26% | -0.39% | -0.4% | -0.4% | 3.3% | 14.24% | 4.03% | 5.28% | 20.22% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Deep Health AI insights
59 extracted metrics + investor summaries across FY11–FY26.
Documents
1
Announcement under Regulation 30 (LODR)-Resignation of Director
11 Sep - Mr. Rajesh Nandkishore Pherwani resigned as Independent Director effective September 11, 2026. 11 Sep - Mr. Rajesh Nandkishore Pherwani resigned as Independent Director effective September 11, 2026.
2
Announcement under Regulation 30 (LODR)-Change in Management
11 Sep - Rajesh Nandkishore Pherwani resigned as Non-Executive Independent Director effective September 11, 2026. 11 Sep - Rajesh Nandkishore Pherwani resigned as Non-Executive Independent Director effective September 11, 2026.
3
Board Meeting Outcome for Outcome Of The Meeting Of The Board Of The Company Held On May 04, 2026.
4 May - Board approved rights issue of fully paid equity shares to raise up to ₹25 crore. 4 May - Board approved rights issue of fully paid equity shares to raise up to ₹25 crore.
4
Board Meeting Outcome for Outcome Of The Meeting Of The Board Of The Company Held On May 04, 2026.
4 May - Board approved rights issue of fully paid equity shares to raise up to ₹25 crore. 4 May - Board approved rights issue of fully paid equity shares to raise up to ₹25 crore.
5
Board Meeting Intimation for Prior Intimation Pursuant To Regulation 29 Of Securities Exchange And Board Of India (LODR) Regulations, 2015 For The Meeting Of The Board Of The Company Scheduled To Be Held On Monday, May 04, 2026.
28 Apr - Board meeting on May 4, 2026 to consider raising funds via rights issue. 28 Apr - Board meeting on May 4, 2026 to consider raising funds via rights issue.
Frequently Asked Questions about Deep Health AI
What does Deep Health AI India Ltd do?
Incorporated in 1993, Deep Diamond India Ltd is in the business of trading Diamond, Jewellery and Pharma products[1]
Where is Deep Health AI India Ltd (539559) listed?
Deep Health AI India Ltd trades as DEEPDIAMONDINDIALTD on the NSE and under code 539559 on the BSE.
Which sector does Deep Health AI India Ltd belong to?
Deep Health AI India Ltd is classified under the Consumer Goods sector, in the Jewellery & Watches industry.
What is the market capitalisation of Deep Health AI India Ltd?
Deep Health AI India Ltd has a market capitalisation of ₹26.49 Cr, which places it in the Small Cap band.
What is the PE ratio of Deep Health AI India Ltd?
Deep Health AI India Ltd trades at a PE ratio of -26.00, on earnings per share of ₹0.12, against a book value of ₹3.56 per share.
What is the 52-week high and low of Deep Health AI India Ltd?
Over the last 52 weeks Deep Health AI India Ltd has traded between ₹1.65 and ₹10.29.
Does Deep Health AI India Ltd pay dividends?
Deep Health AI India Ltd has a dividend yield of 5.49%.
What is the Return on Equity (ROE) of Deep Health AI India Ltd?
Deep Health AI India Ltd reported a return on equity of 3.92%. Its debt-to-equity ratio is 0.01.
Company Information
Incorporated in 1993, Deep Diamond India Ltd is in the business of trading Diamond, Jewellery and Pharma products[1]
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/539559.md for Deep Health AI India Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live,
structured queries instead of documents, use our MCP server.